Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL E-PRESCRIBING MARKET SIZE TO CROSS USD 3 BILLION IN 2026, GROWING AT A CAGR OF OVER 21% DURING 2021-2026
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL E-PRESCRIBING MARKET REPORT SCOPE
REPORT ATTRIBUTE | DETAILS |
---|---|
MARKET SIZE (REVENUE) | USD 3 BILLION (2026) |
CAGR | 21% (2021–2026) |
Base Year | 2020 |
Forecast Year | 2021-2026 |
Market Segments | Type (Standard E-Prescribing, Electronic Prescribing for Controlled Substances (EPCS)); Delivery Mode (Web-Based, Cloud-Based, and On-Premise or Desktop-Based); Modality (Integrated and Standalone); Medication (Cardiovascular, Oncology, Anti-infective, Behavioral & Mental Health, Pain Medication and Others); End-User (Healthcare Facilities, Technology Vendors, Independent & Specialty Pharmacies, and PBM & Payors) |
Geographic Analysis | North America, Europe, APAC, Latin America, and the Middle East & Africa |
Countries Covered | US, Canada, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Mexico, Brazil, Saudi Arabia, Turkey, South Africa |
E-PRESCRIBING INDUSTRY INSIGHTS
The global e-prescribing market size was valued at USD 960 million in 2020 and is expected to reach USD 3 billion in 2026, growing at a CAGR of 21% during the forecast period.
There has been steady growth in the adoption of national electronic health records (EHR) systems and witnessed a 46% increase in implementation over the past five years. With the introduction of e-prescribing solutions, its integration with EHRs has highly increased. The advanced features such as clinical decision support, patient management systems, electronic prior authorization, and many others are accelerating the demand for e-prescribing solutions. In 2020, the standard eprescribing market accounted for the largest share of 92.52%. The web and cloud-based segment is likely to witness the highest incremental growth of USD 1,668.74 and absolute growth of 226.17% during the forecast period. North America dominated the global e-prescribing market followed by Europe.
Surescripts’ e-prescribing platform hit the 1 million prescriber mark during the spread of COVID-19. The pandemic has generated a shift toward telehealth as part of the solution for breaking community transmission. Outpatient visits dropped roughly 60% during March 2019, which boosted telehealth visits up to 46% across health facilities. With the decrease in ambulatory care visits and an increase in telehealth or remote visits, health organizations and clinicians have leveraged health IT and electronic health records (EHR) to provide optimal patient care.
E-PRESCRIBING MARKET GROWTH ENABLERS
- In the US, the federal government has played a significant role in encouraging the use of e-prescribing technology and stimulating associated research nationwide. The federal government has also increased e-prescribing research initiatives through agencies such as the Agency for Healthcare Research and Quality (AHRQ) and the Health Resources and Services Administration (HRSA).
- The development of indication e-prescribing allows clear assessments of drug effectivity to support the research of drug outcomes and make prompt changes in labeling or prescribing drugs for off-label use. The Agency for Healthcare Research and Quality (AHRQ) has funded a three-year project to create and test a prototype system.
- Digital transformation in healthcare and electronic prescribing services has become significant and critical to offer quality patient care. Quality and optimization of e-prescribing are key focus areas for digital transformation. For instance, Surescripts has offered information regarding quality-related transactions, such as the Structured and Codified Sig.
E-PRESCRIBING MARKET SEGMENTATION
This research report includes a detailed segmentation by
- Type
- Delivery Mode
- Modality
- Medication Type
- End-user
- Geography
Standard solutions are likely to grow at a CAGR of over 21% during 2020–2026 due to the high prevalence of prescription errors in health centers.
In 2020, standard e-prescribing solutions accounted for a significant share of over 92%, and they expect to observe an incremental growth of over USD 1.9 million during the forecast period. The modern e-prescribing system is a robust technology that facilitates an interactive data transaction. Transactions in the e-prescribing software allow prescribers to view the complete profile of the patients’ medication. The software increases the effectiveness and efficiency of patient care through automated clinical decision support and tracking complete medication profiles. Electronic prescribing for controlled substances (EPCS) is likely to grow, with the highest CAGR of over 23% during the forecast period. EPCS technology help to streamline the prescriber’s workflow, improve medication safety, and reduce drug diversions and frauds. In the US, 28 states have already mandated the use of EPCS.
Web & Cloud-based solutions expect to account for approx. USD 2.4 billion by 2026 due to the demand for effective and efficient health services.
In terms of delivery, web and cloud-based software held a major share of over 76% in 2020. The segment is likely to witness the highest incremental growth of over USD 1.6 billion during the forecast period. Web and cloud-based solutions are utilized by many healthcare settings such as hospitals, pharmacies, and ambulatory centers; hence, their demand is high during the forecast period. The global on-premise & desktop e-prescribing market is likely to reach over USD 645 million by 2026, growing at a CAGR of over 19%. On-premises solutions are less advanced than web and cloud-based solutions and lack the capabilities to stay current with security, performance, and reliability. However, on-premise software resides within the organization’s premises and offers higher security, protection, and control than cloud computing infrastructure.
Integrated solutions are likely to observe an incremental growth of USD 1.9 billion by 2026 due to an increased focus on security, patient privacy, and the prevention of fraudulent medical activities.
Integrated e-prescribing solutions are in high demand, accounting for a major share of 87% of the segment. Eprescribing software integrated with EHR is highly preferred compared to standalone systems. Integrated software is likely to witness the highest absolute growth of approx. 225% and growing with a CAGR of over 21% during the forecast period. Vendors are increasingly focusing on integrating EHR into e-prescribing solutions. Standalone accounted for over 13% of the global e-prescribing market share in 2020. Standalone e-prescribe systems are economical than integrated solutions. It is considered an efficient way to transit to electronic data and workflow management or telehealth capabilities.
Cardiovascular solutions are likely to grow at a CAGR of over 20% during 2020–2026 because of the increasing prevalence of cardiovascular diseases.
Cardiovascular drugs are the most commonly e-prescribed medications due to the increasing prevalence of heart disorders. With the increased utilization of cardiovascular drugs, e-prescribing has highly increased. EHRs that are used for e-prescribing cardiovascular drugs are also increasingly adopted by prescribers. Several companies have developed cardiology-based EHR software solutions, which are highly utilized for eprescribing and integrated with EHR systems.
Healthcare facilities are likely to adopt at a favorable rate of 25% during 2020–2026 due to the inherent complexity of the medication process and contextual factors.
Technology vendors, independent and specialty pharmacies, healthcare facilities, and pharmacy benefits management and payors are the major end-users of the e-prescribing market. Technology vendors accounted for the highest share of over 73% and will witness an incremental growth of USD 1.4 billion during the forecast period. E-prescribing is rapidly growing in the telehealth field due to its substantial benefits for office-based physicians’ workflow and patient safety. Vendors are customizing their telehealth services by including electronic prescribing. Electronic prescriptions integrated with advanced telehealth solutions can be used for routine check-ups or prescription refills.
SEGMENTATION BY GEOGRAPHY
Europe is likely to grow at the highest CAGR of over 23% during the forecast period due to high medication errors and increased opioid-related mortalities.
The North American e-prescribing market expects to reach over USD 1.2 billion by 2026, growing at a CAGR of over 20% during the forecast period. Major factors contributing to the largest share include the growing focus on decreasing prescription errors, reduce controlled substance abuse, increasing adoption of EHR solutions, government incentives, and initiatives for implementing e-prescribing across healthcare settings. Advances in software and increased digitalization in healthcare IT infrastructure contribute to the high adoption of e-prescribing in the region. Rising concerns over prescription errors resulting in drug overdose deaths are driving the demand for U.S. E-prescribing market growth. The Europe e-prescribing market is expected to grow at a CAGR of around 23% during the forecast period.
COMPETITIVE LANDSCAPE
The global e-prescribing market is likely to witness the entry of new players and increased collaboration with major software vendors. The prominent players in the market are Surescripts, DrFirst, Practice Fusion, and Insync Healthcare Solutions. Several key players are integrating eprescribing services with EHR software to increase product differentiation among end-users. They focus on providing integrated services, which contributes to the market share. Primary healthcare settings utilize integrated services, and standalone has become limited to private clinics or small healthcare facilities.
The global e-prescribing market research report includes in-depth coverage of the industry analysis with revenue, market trends, and forecast insights for the following segments:
Type
- Standard E-prescribing
- Electronic Prescribing for Controlled Substances
Delivery Mode
- Web & Cloud-based
- On-premise & Desktop
Modality
- Integrated
- Standalone
Medication Type
- Cardiovascular
- Anti-infectives
- Oncology
- Pain Medication
- Behavioral & Mental Health
- Others
End-user
- Technology Vendors
- Independent & Specialty Pharmacies
- Healthcare Facilities
- Pharmacy Benefit Management (PBM) & Payors
Geography
- North America
- US
- Canada
- Europe
- UK
- Italy
- Spain
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- Turkey
- South Africa
Frequently Asked Questions
How big is the global e-prescribing market?
What is the e-prescribing market growth?
Which segment accounted for the largest e prescribing market share?
What are the key driving factors for the e-prescribing market?
Who are the leading players in the e-prescribing market?
What is the top e-prescribing industry trend in the United States?
The global e-prescribing market by revenue is expected to grow at a CAGR of over 21% during the period 2020–2026.
The following factors are likely to contribute to the growth of the e-prescribing market during the forecast period:
- Development of Indication-based Prescribing Systems
- Outsourcing of E-prescribing Software & Development of E-prescribing Applications
- Advances in E-prescribing Solutions
- Increased Demand for Electronic Health Record Services
Base Year: 2020
Forecast Year: 2021–2026
The study considers the global e-prescribing market’s present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
- Surescripts
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- DrFirst
- Practice Fusion
- InSync Healthcare Solutions
Other Prominent Vendors
- eRx Network
- Business Overview
- Product Offerings
- Henry Schein
- AdvancedMD
- MD Toolbox
- Bravado Health
- RXNT
- Daw Systems
- DoseSpot
- Chetu Inc.
- Aegis Healthcare
- SISGAIN
- Credible
- Streamline Healthcare Solutions
- Canada Health Infoway
- DrChrono
- Bizmatics
Type
- Standard E-prescribing
- Electronic Prescribing for Controlled Substances
Delivery Mode
- Web & Cloud-based
- On-premise & Desktop
Modality
- Integrated
- Standalone
Medication Type
- Cardiovascular
- Anti-infectives
- Oncology
- Pain Medication
- Behavioral & Mental Health
- Others
End-user
- Technology Vendors
- Independent & Specialty Pharmacies
- Healthcare Facilities
- Pharmacy Benefit Management (PBM) & Payors
Geography
- North America
- US
- Canada
- Europe
- UK
- Italy
- Spain
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- Turkey
- South Africa
List of Exhibits
Exhibit 1 Segmentation of Global E-prescribing Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Graduated levels of Electronic Prescribing
Exhibit 4 Impact of Development of Indication-based E-Prescribing Systems
Exhibit 5 Impact of Outsourcing E-prescribing Software Development
Exhibit 6 Impact of Advancements in E-Prescribing Solutions
Exhibit 7 Timeline for the development of e-prescribing from EHR
Exhibit 8 Evolution of E-prescribing
Exhibit 9 Impact of Increased demand for EHR services
Exhibit 10 Impact of Government Initiatives & Incentive Programs
Exhibit 11 Impact of Prescription Error Prevention & Clinical Decision Support Automation
Exhibit 12 Impact of Increasing Focus to Reduce & Monitor Controlled Substances
Exhibit 13 Statistics of electronic prescribing of controlled substances
Exhibit 14 Impact of E-Prescribing & E-Formulary Errors
Exhibit 15 Impact of High Cost of Development & Security Concerns
Exhibit 16 Impact of Complex Technology & Software Designing Issues
Exhibit 17 Global E-Prescribing Market 2020–2026 ($ million)
Exhibit 18 Global E-prescribing Market by Geography
Exhibit 19 Global E-prescribing Market by Type
Exhibit 20 Global E-prescribing Market by Delivery Mode
Exhibit 21 Global E-prescribing Market by Modality
Exhibit 22 Global E-prescribing Market by Medication Type
Exhibit 23 Global E-prescribing Market by End user
Exhibit 24 Five Forces Analysis 2020
Exhibit 25 Incremental Growth by Type 2020 & 2026
Exhibit 26 Global E-prescribing Market by Type
Exhibit 27 Rate of E-prescribing by Surescripts
Exhibit 28 Global E-prescribing Market by Type: Incremental Growth
Exhibit 29 Global E-prescribing Market by Type: Absolute Growth
Exhibit 30 Number of E-prescriptions by Surescripts (billion)
Exhibit 31 Global E-prescribing Market by Standard E-prescribing: Incremental & Absolute Growth
Exhibit 32 E-prescribing by Pharmacies and Prescribers (%)
Exhibit 33 Global E-prescribing Market by Standard E-prescribing Segment 2020–2026 ($ million)
Exhibit 34 Incremental Growth by Geography 2020 & 2026
Exhibit 35 Number of E-prescribing for Controlled Substances by Surescripts (million)
Exhibit 36 E-prescribing for Controlled Substances by Pharmacies and Prescribers (%)
Exhibit 37 Global E-prescribing Market by EPCS: Incremental & Absolute Growth
Exhibit 38 Global E-prescribing Market by EPCS 2020–2026 ($ million)
Exhibit 39 Incremental Growth by Geography 2020 & 2026
Exhibit 40 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 41 Global E-prescribing Market by Delivery Mode
Exhibit 42 Global E-prescribing Market by Delivery Mode: Incremental Growth
Exhibit 43 Global E-prescribing Market by Delivery Mode: Absolute Growth
Exhibit 44 Global E-prescribing Market by Web & Cloud-based: Incremental & Absolute Growth
Exhibit 45 Global E-prescribing Market by Web & Cloud-based 2020–2026 ($ million)
Exhibit 46 Incremental Growth by Geography 2020 & 2026
Exhibit 47 Global E-prescribing Market by On-Premises & Desktop: Incremental & Absolute Growth
Exhibit 48 Global E-prescribing Market by On-Premises & Desktop 2020–2026 ($ million)
Exhibit 49 Incremental Growth by Geography 2020 & 2026
Exhibit 50 Incremental Growth by Modality 2020 & 2026
Exhibit 51 Global E-prescribing Market by Modality
Exhibit 52 Prescribers using standalone and integrated e-prescribing (2012)
Exhibit 53 Global E-prescribing Market by Modality: Incremental Growth
Exhibit 54 Global E-prescribing Market by Modality: Absolute Growth
Exhibit 55 Global E-prescribing Market by Integrated: Incremental & Absolute Growth
Exhibit 56 Global E-prescribing Market by Integrated 2020–2026 ($ million)
Exhibit 57 Incremental Growth by Geography 2020 & 2026
Exhibit 58 Global E-prescribing Market by Standalone: Incremental & Absolute Growth
Exhibit 59 Global E-prescribing Market by Standalone 2020–2026 ($ million)
Exhibit 60 Incremental Growth by Geography 2020 & 2026
Exhibit 61 Incremental Growth by Medication Type 2020 & 2026
Exhibit 62 Global E-prescribing Market by Medication Type
Exhibit 63 E-prescribing various classes of medications (%)
Exhibit 64 Top five specialties using EPCS (2019)
Exhibit 65 Global E-prescribing Market by Medication Type: Incremental Growth
Exhibit 66 Global E-prescribing Market by Cardiovascular: Incremental & Absolute Growth
Exhibit 67 Global E-prescribing Market by Cardiovascular 2020–2026 ($ million)
Exhibit 68 Incremental Growth by Geography 2020 & 2026
Exhibit 69 Global E-prescribing Market by Anti-infectives: Incremental & Absolute Growth
Exhibit 70 Global E-prescribing Market by Anti-infectives 2020–2026 ($ million)
Exhibit 71 Incremental Growth by Geography 2020 & 2026
Exhibit 72 Global E-prescribing Market by Oncology: Incremental & Absolute Growth
Exhibit 73 Global E-prescribing Market by Oncology 2020–2026 ($ million)
Exhibit 74 Incremental Growth by Geography 2020 & 2026
Exhibit 75 E-prescribing of Opioids by Surescripts (million)
Exhibit 76 Top five opioid E-prescription by Surescripts (2019)
Exhibit 77 Global E-prescribing Market by Pain medication: Incremental & Absolute Growth
Exhibit 78 Global E-prescribing Market by Pain medication 2020–2026 ($ million)
Exhibit 79 Incremental Growth by Geography 2020 & 2026
Exhibit 80 Global E-prescribing Market by Behavioral & mental health: Incremental & Absolute Growth
Exhibit 81 Global E-prescribing Market Behavioral & mental health 2020–2026 ($ million)
Exhibit 82 Incremental Growth by Geography 2020 & 2026
Exhibit 83 Global E-prescribing Market by Others: Incremental & Absolute Growth
Exhibit 84 Global E-prescribing Market by Others 2020–2026 ($ million)
Exhibit 85 Incremental Growth by Geography 2020 & 2026
Exhibit 86 Incremental Growth by End-user 2020 & 2026
Exhibit 87 Global E-prescribing Market by End user
Exhibit 88 Global E-prescribing Market by End user: Incremental Growth
Exhibit 89 Global E-prescribing Market by End user: Absolute Growth
Exhibit 90 Global E-prescribing Market by Technology Vendors: Incremental & Absolute Growth
Exhibit 91 Prescribers utilizing EHR and standalone e-prescribing on Surescripts network in 2013 (%)
Exhibit 92 Global E-prescribing Market by Technology Vendors 2020–2026 ($ million)
Exhibit 93 Incremental Growth by Geography 2020 & 2026
Exhibit 94 Global E-prescribing Market by Independent & Specialty Pharmacies: Incremental & Absolute Growth
Exhibit 95 E-prescribing Specialty Drugs as Percentage of Total Drug Spend
Exhibit 96 Global E-prescribing Market by Independent & Specialty Pharmacies Market 2020–2026 ($ million)
Exhibit 97 Incremental Growth by Geography 2020 & 2026
Exhibit 98 Global E-prescribing Market by Healthcare Facilities: Incremental & Absolute Growth
Exhibit 99 Global E-prescribing Market by Healthcare Facilities 2020–2026 ($ million)
Exhibit 100 Incremental Growth by Geography 2020 & 2026
Exhibit 101 Global E-prescribing Market by PBM & Payors: Incremental & Absolute Growth
Exhibit 102 Global E-prescribing Market by PBM & Payors 2020–2026 ($ million)
Exhibit 103 Incremental Growth by Geography 2020 & 2026
Exhibit 104 Incremental Growth by Geography 2020 & 2026
Exhibit 105 Global E-prescribing Market by Geography
Exhibit 106 Global E-prescribing Market by Geography: Incremental Growth
Exhibit 107 Global E-prescribing Market by Geography: Absolute Growth
Exhibit 108 Global E-prescribing Market by Geography: Key Countries ($ million)
Exhibit 109 E-prescribing Market in North America: Key Countries
Exhibit 110 North America E-prescribing Market: Incremental & Absolute Growth Comparison
Exhibit 111 E-prescribing Market in North America 2020–2026 ($ million)
Exhibit 112 Incremental Growth by Type 2020 & 2026
Exhibit 113 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 114 Incremental Growth by Modality 2020 & 2026
Exhibit 115 Incremental Growth by Medication Type 2020 & 2026
Exhibit 116 Incremental Growth by End user 2020 & 2026
Exhibit 117 Incremental Growth in North America 2020 & 2026
Exhibit 118 EHR adoption rate in the US (%)
Exhibit 119 E-prescribing Market in the US 2020–2026 ($ million)
Exhibit 120 E-prescribing Market in Canada 2020–2026 ($ million)
Exhibit 121 E-prescribing Market in Europe: Key Countries
Exhibit 122 Growth of e-prescribing in primary care in Europe (%)
Exhibit 123 Europe E-prescribing Market: Incremental & Absolute Growth
Exhibit 124 E-prescribing Market in Europe 2020–2026 ($ million)
Exhibit 125 Incremental Growth by Type 2020 & 2026
Exhibit 126 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 127 Incremental Growth by Modality 2020 & 2026
Exhibit 128 Incremental Growth by Medication Type 2020 & 2026
Exhibit 129 Incremental Growth by End user 2020 & 2026
Exhibit 130 Incremental Growth in Europe 2020 & 2026
Exhibit 131 E-prescribing Market in UK 2020–2026 ($ million)
Exhibit 132 E-prescribing Market in Italy 2020–2026 ($ million)
Exhibit 133 E-prescribing Market in Spain 2020–2026 ($ million)
Exhibit 134 E-prescribing Market in APAC: Key Countries
Exhibit 135 Annual prevalence for the use of opioids in Asia in 2017 (%)
Exhibit 136 APAC E-prescribing Market: Incremental & Absolute Growth
Exhibit 137 E-prescribing Market in APAC 2020–2026 ($ million)
Exhibit 138 Incremental Growth by Type 2020 & 2026
Exhibit 139 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 140 Incremental Growth by Modality 2020 & 2026
Exhibit 141 Incremental Growth by Medication Type 2020 & 2026
Exhibit 142 Incremental Growth by End user 2020 & 2026
Exhibit 143 Incremental Growth in APAC 2020 & 2026
Exhibit 144 E-prescribing Market in China 2020–2026 ($ million)
Exhibit 145 E-prescribing Market in Japan 2020–2026 ($ million)
Exhibit 146 E-prescribing Market in Australia 2020–2026 ($ million)
Exhibit 147 E-prescribing Market in India 2020–2026 ($ million)
Exhibit 148 E-prescribing Market in South Korea 2020–2026 ($ million)
Exhibit 149 E-prescribing Market in Latin America: Key Countries
Exhibit 150 Latin America E-prescribing Market: Incremental & Absolute Growth
Exhibit 151 E-prescribing Market in Latin America 2020–2026 ($ million)
Exhibit 152 Incremental Growth by Type 2020 & 2026
Exhibit 153 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 154 Incremental Growth by Modality 2020 & 2026
Exhibit 155 Incremental Growth by Medication Type 2020 & 2026
Exhibit 156 Incremental Growth by End user 2020 & 2026
Exhibit 157 Incremental Growth in Latin America 2020 & 2026
Exhibit 158 E-prescribing Market in Brazil 2020–2026 ($ million)
Exhibit 159 E-prescribing Market in Mexico 2020–2026 ($ million)
Exhibit 160 E-prescribing Market in Argentina 2020–2026 ($ million)
Exhibit 161 E-prescribing Market in Middle East & Africa: Key Countries
Exhibit 162 Middle East & Africa E-prescribing Market: Incremental & Absolute Growth
Exhibit 163 E-prescribing Market in Middle East & Africa 2020–2026 ($ million)
Exhibit 164 Incremental Growth by Type 2020 & 2026
Exhibit 165 Incremental Growth by Delivery Mode 2020 & 2026
Exhibit 166 Incremental Growth by Modality 2020 & 2026
Exhibit 167 Incremental Growth by Medication Type 2020 & 2026
Exhibit 168 Incremental Growth by End-user 2020 & 2026
Exhibit 169 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 170 E-prescribing Market in South Africa 2020–2026 ($ million)
Exhibit 171 E-prescribing Market in Saudi Arabia 2020–2026 ($ million)
Exhibit 172 E-prescribing Market in Turkey 2020–2026 ($ million)
Exhibit 173 Global e-Prescribing Market: Vendors Market Shares 2020
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Consequences of E-prescribing errors
Table 4 Cost associated with basic e-prescribing and EPCS in most widely used EHRs
Table 5 Pros & Cons for Standalone & Integrated E-prescribing solutions
Table 6 North America E-prescribing Market by Type 2020−2026 ($ million)
Table 7 North America E-prescribing Market by Type 2020−2026 (%)
Table 8 North America E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 9 North America E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 10 North America E-prescribing Market by Modality 2020−2026 ($ million)
Table 11 North America E-prescribing Market by Modality 2020−2026 (%)
Table 12 North America E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 13 North America E-prescribing Market by Medication Type 2020−2026 (%)
Table 14 North America E-prescribing Market by End user 2020−2026 ($ million)
Table 15 North America E-prescribing Market by End user 2020−2026 (%)
Table 16 Europe E-prescribing Market by Type 2020−2026 ($ million)
Table 17 Europe E-prescribing Market by Type 2020−2026 (%)
Table 18 Europe E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 19 Europe E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 20 Europe E-prescribing Market by Modality 2020−2026 ($ million)
Table 21 Europe E-prescribing Market by Modality 2020−2026 (%)
Table 22 Europe E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 23 Europe E-prescribing Market by Medication Type 2020−2026 (%)
Table 24 Europe E-prescribing Market by End user 2020−2026 ($ million)
Table 25 Europe E-prescribing Market by End user 2020−2026 (%)
Table 26 APAC E-prescribing Market by Type 2020−2026 ($ million)
Table 27 APAC E-prescribing Market by Type 2020−2026 (%)
Table 28 APAC E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 29 APAC E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 30 APAC E-prescribing Market by Modality 2020−2026 ($ million)
Table 31 APAC E-prescribing Market by Modality 2020−2026 (%)
Table 32 APAC E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 33 APAC E-prescribing Market by Medication Type 2020−2026 (%)
Table 34 APAC E-prescribing Market by End user 2020−2026 ($ million)
Table 35 APAC E-prescribing Market by End user 2020−2026 (%)
Table 36 Latin America E-prescribing Market by Type 2020−2026 ($ million)
Table 37 Latin America E-prescribing Market by Type 2020−2026 (%)
Table 38 Latin America E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 39 Latin America E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 40 Latin America E-prescribing Market by Modality 2020−2026 ($ million)
Table 41 Latin America E-prescribing Market by Modality 2020−2026 (%)
Table 42 Latin America E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 43 Latin America E-prescribing Market by Medication Type 2020−2026 (%)
Table 44 Latin America E-prescribing Market by End user 2020−2026 ($ million)
Table 45 Latin America E-prescribing Market by End user 2020−2026 (%)
Table 46 Middle East & Africa E-prescribing Market by Type 2020−2026 ($ million)
Table 47 Middle East & Africa E-prescribing Market by Type 2020−2026 (%)
Table 48 Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 49 Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 50 Middle East & Africa E-prescribing Market by Modality 2020−2026 ($ million)
Table 51 Middle East & Africa E-prescribing Market by Modality 2020−2026 (%)
Table 52 Middle East & Africa E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 53 Middle East & Africa E-prescribing Market by Medication Type 2020−2026 (%)
Table 54 Middle East & Africa E-prescribing Market by End user 2020−2026 ($ million)
Table 55 Middle East & Africa E-prescribing Market by End user 2020−2026 (%)
Table 56 Surescripts: Major Product Offerings
Table 57 DrFirst: Major Product Offerings
Table 58 Practice Fusion: Major Product Offerings
Table 59 Company 1: Major Product Offerings
Table 60 eRx Network: Major Product Offerings
Table 61 Henry Schein: Major Product Offerings
Table 62 AdvancedMD: Major Product Offerings
Table 63 MD Toolbox: Major Product Offerings
Table 64 Bravado Health: Major Product Offerings
Table 65 RXNT: Major Product Offerings
Table 66 Daw Systems: Major Product Offerings
Table 67 DoseSpot: Major Product Offerings
Table 68 Chetu Inc: Major Product Offerings
Table 69 Aegis Healthcare: Major Product Offerings
Table 70 SISGAIN: Major Product Offerings
Table 71 Credible: Major Product Offerings
Table 72 Streamline Healthcare Solutions: Major Product Offerings
Table 73 Canada Health Infoway: Major Product Offerings
Table 74 DrChrono: Major Product Offerings
Table 75 Bizmatics: Major Product Offerings
Table 76 Global E-prescribing Market by Type 2020−2026 ($ million)
Table 77 Global E-prescribing Market by Type 2020−2026 (%)
Table 78 North America E-prescribing Market by Type 2020−2026 ($ million)
Table 79 North America E-prescribing Market by Type 2020−2026 (%)
Table 80 Europe E-prescribing Market by Type 2020−2026 ($ million)
Table 81 Europe E-prescribing Market by Type 2020−2026 (%)
Table 82 APAC E-prescribing Market by Type 2020−2026 ($ million)
Table 83 APAC E-prescribing Market by Type 2020−2026 (%)
Table 84 Latin America E-prescribing Market by Type 2020−2026 ($ million)
Table 85 Latin America E-prescribing Market by Type 2020−2026 (%)
Table 86 Middle East & Africa E-prescribing Market by Type 2020−2026 ($ million)
Table 87 Middle East & Africa E-prescribing Market by Type 2020−2026 (%)
Table 88 Global E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 89 Global E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 90 North America E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 91 North America E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 92 Europe E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 93 Europe E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 94 APAC E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 95 APAC E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 96 Latin America E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 97 Latin America E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 98 Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 ($ million)
Table 99 Middle East & Africa E-prescribing Market by Delivery Mode 2020−2026 (%)
Table 100 Global E-prescribing Market by Modality 2020−2026 ($ million)
Table 101 Global E-prescribing Market by Modality 2020−2026 (%)
Table 102 North America E-prescribing Market by Modality 2020−2026 ($ million)
Table 103 North America E-prescribing Market by Modality 2020−2026 (%)
Table 104 Europe E-prescribing Market by Modality 2020−2026 ($ million)
Table 105 Europe E-prescribing Market by Modality 2020−2026 (%)
Table 106 APAC E-prescribing Market by Modality 2020−2026 ($ million)
Table 107 APAC E-prescribing Market by Modality 2020−2026 (%)
Table 108 Latin America E-prescribing Market by Modality 2020−2026 ($ million)
Table 109 Latin America E-prescribing Market by Modality 2020−2026 (%)
Table 110 Middle East & Africa E-prescribing Market by Modality 2020−2026 ($ million)
Table 111 Middle East & Africa E-prescribing Market by Modality 2020−2026 (%)
Table 112 Global E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 113 Global E-prescribing Market by Medication Type 2020−2026 (%)
Table 114 North America E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 115 North America E-prescribing Market by Medication Type 2020−2026 (%)
Table 116 Europe E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 117 Europe E-prescribing Market by Medication Type 2020−2026 (%)
Table 118 APAC E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 119 APAC E-prescribing Market by Medication Type 2020−2026 (%)
Table 120 Latin America E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 121 Latin America E-prescribing Market by Medication Type 2020−2026 (%)
Table 122 Middle East & Africa E-prescribing Market by Medication Type 2020−2026 ($ million)
Table 123 Middle East & Africa E-prescribing Market by Medication Type 2020−2026 (%)
Table 124 Global E-prescribing Market by End user 2020−2026 ($ million)
Table 125 Global E-prescribing Market by End user 2020−2026 (%)
Table 126 North America E-prescribing Market by End user 2020−2026 ($ million)
Table 127 North America E-prescribing Market by End user 2020−2026 (%)
Table 128 Europe E-prescribing Market by End user 2020−2026 ($ million)
Table 129 Europe E-prescribing Market by End user 2020−2026 (%)
Table 130 APAC E-prescribing Market by End user 2020−2026 ($ million)
Table 131 APAC E-prescribing Market by End user 2020−2026 (%)
Table 132 Latin America E-prescribing Market by End user 2020−2026 ($ million)
Table 133 Latin America E-prescribing Market by End user 2020−2026 (%)
Table 134 Middle East & Africa E-prescribing Market by End user 2020−2026 ($ million)
Table 135 Middle East & Africa E-prescribing Market by End user 2020−2026 (%)
Table 136 Global E-prescribing Market by Geography 2020−2026 ($ million)
Table 137 Global E-prescribing Market by Geography 2020−2026 (%)
Table 138 Standard E-prescribing in E-prescribing Market by Geography 2020−2026 ($ million)
Table 139 Standard E-prescribing in E-prescribing Market by Geography 2020−2026 (%)
Table 140 EPCS in E-prescribing Market by Geography 2020−2026 ($ million)
Table 141 EPCS in E-prescribing Market by Geography 2020−2026 (%)
Table 142 Web & Cloud-based in E-prescribing Market by Geography 2020−2026 ($ million)
Table 143 Web & Cloud-based in E-prescribing Market by Geography 2020−2026 (%)
Table 144 On-Premises & Desktop in E-prescribing Market by Geography 2020−2026 ($ million)
Table 145 On-Premises & Desktop in E-prescribing Market by Geography 2020−2026 (%)
Table 146 Integrated in E-prescribing Market by Geography 2020−2026 ($ million)
Table 147 Integrated in E-prescribing Market by Geography 2020−2026 (%)
Table 148 Standalone in E-prescribing Market by Geography 2020−2026 ($ million)
Table 149 Standalone in E-prescribing Market by Geography 2020−2026 (%)
Table 150 Cardiovascular in E-prescribing Market by Geography 2020−2026 ($ million)
Table 151 Cardiovascular in E-prescribing Market by Geography 2020−2026 (%)
Table 152 Anti-infectives in E-prescribing Market by Geography 2020−2026 ($ million)
Table 153 Anti-infectives in E-prescribing Market by Geography 2020−2026 (%)
Table 154 Oncology in E-prescribing Market by Geography 2020−2026 ($ million)
Table 155 Oncology in E-prescribing Market by Geography 2020−2026 (%)
Table 156 Pain Medication in E-prescribing Market by Geography 2020−2026 ($ million)
Table 157 Pain Medication in E-prescribing Market by Geography 2020−2026 (%)
Table 158 Behavioral & Mental Health in E-prescribing Market by Geography 2020−2026 ($ million)
Table 159 Behavioral & Mental Health in E-prescribing Market by Geography 2020−2026 (%)
Table 160 Others in E-prescribing Market by Geography 2020−2026 ($ million)
Table 161 Others in E-prescribing Market by Geography 2020−2026 (%)
Table 162 Technology Vendors in E-prescribing Market by Geography 2020−2026 ($ million)
Table 163 Technology Vendors in E-prescribing Market by Geography 2020−2026 (%)
Table 164 Independent & Specialty Pharmacies in E-prescribing Market by Geography 2020−2026 ($ million)
Table 165 Independent & Specialty Pharmacies in E-prescribing Market by Geography 2020−2026 (%)
Table 166 Healthcare Facilities in E-prescribing Market by Geography 2020−2026 ($ million)
Table 167 Healthcare Facilities in E-prescribing Market by Geography 2020−2026 (%)
Table 168 PBM & Payors in E-prescribing Market by Geography 2020−2026 ($ million)
Table 169 PBM & Payors in E-prescribing Market by Geography 2020−2026 (%)
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation by Type
4.3.2 Market Segmentation by Delivery Mode
4.3.3 Market Segmentation by Modality
4.3.4 Market Segmentation by Medication Type
4.3.5 Market Segmentation by End User
4.3.6 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market At A Glance
7 Introduction
7.1 Overview
7.1.1 Features of an Ideal Electronic Prescribing System
7.1.2 Standards for Electronic Prescription Systems
8 Market Opportunities & Trends
8.1 Development Of Indication-Based E-Prescribing Systems
8.2 Outsourcing E-Prescribing Software Development
8.3 Advancements In E-Prescribing Solutions
9 Market Growth Enablers
9.1 Increased Demand For EHR Services
9.2 Government Initiatives & Incentive Programs
9.3 Prescription Error Prevention & Clinical Decision Support Automation
9.4 Increasing Focus To Reduce & Monitor Controlled Substances
10 Market Restraints
10.1 E-Prescribing & E-Formulary Errors
10.2 High Cost of Deployment & Security Concerns
10.3 Complex Technology & Software Designing Issues
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Impact Of COVID-19
11.4 Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Standard E-Prescribing
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Standard E-prescribing: Geography Segmentation
12.4 EPCS
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 EPCS: Geography Segmentation
13 Delivery Mode
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Web & Cloud-Based
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Web & Cloud-Based: Geography Segmentation
13.4 On-Premises & Desktop
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 On-Premises & Desktop: Geography Segmentation
14 Modality
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Integrated
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Integrated: Geography Segmentation
14.4 Standalone
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Standalone: Geography Segmentation
15 Medication Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Cardiovascular
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Cardiovascular: Geography Segmentation
15.4 Anti-Infectives
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Anti-Infectives: Geography Segmentation
15.5 Oncology
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Oncology: Geography Segmentation
15.6 Pain Management
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.6.3 Pain Medication: Geography Segmentation
15.7 Behavioral & Mental Health
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.7.3 Behavioral & Mental Health: Geography Segmentation
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast
15.8.3 Others: Geography Segmentation
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Technology Vendors
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Technology Vendors: Geography Segmentation
16.4 Independent And Specialty Pharmacies
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Independent & Specialty Pharmacies: Geography Segmentation
16.5 Healthcare Facilities
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Healthcare Facilities: Geography Segmentation
16.6 PBMS / PAYORS
16.6.1 Market Overview
16.6.2 Market Size & Forecast
16.6.3 PBM & Payors: Geography Segmentation
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 North America: Type Segmentation
18.2.2 North America: Delivery Mode
18.2.3 North America: Modality
18.2.4 North America: Medication Type
18.2.5 North America: End user
18.3 Key Countries
18.3.1 US: Market Size & Forecast
18.3.2 Canada: Market Size & Forecast
19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 Europe: Type
19.2.2 Europe: Delivery Mode
19.2.3 Europe: Modality
19.2.4 Europe: Medication Type
19.2.5 Europe: End user
19.3 Key Countries
19.3.1 UK: Market Size & Forecast
19.3.2 Italy: Market Size & Forecast
19.3.3 Spain: Market Size & Forecast
20 APAC
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 APAC: Type
20.2.2 APAC: Delivery Mode
20.2.3 APAC: Modality
20.2.4 APAC: Medication Type
20.2.5 APAC: End user
20.3 Key Countries
20.3.1 China: Market Size & Forecast
20.3.2 Japan: Market Size & Forecast
20.3.3 Australia: Market Size & Forecast
20.3.4 India: Market Size & Forecast
20.3.5 South Korea: Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Latin America: Type
21.2.2 Latin America: Delivery Mode
21.2.3 Latin America: Modality
21.2.4 Latin America: Medication Type
21.2.5 Latin America: End user
21.3 Key Countries
21.3.1 Brazil: Market Size & Forecast
21.3.2 Mexico: Market Size & Forecast
21.3.3 Argentina: Market Size & Forecast
22 Middle East & Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.2.1 Middle East & Africa: Type
22.2.2 Middle East & Africa: Delivery Mode
22.2.3 Middle East & Africa: Modality
22.2.4 Middle East & Africa: Medication Type
22.2.5 Middle East & Africa: End user
22.3 Key Countries
22.3.1 South Africa: Market Size & Forecast
22.3.2 Saudi Arabia: Market Size & Forecast
22.3.3 Turkey: Market Size & Forecast
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Surescripts in E-prescribing Market
23.2.2 DrFirst in E-prescribing Market
23.2.3 Practice Fusion in E-prescribing Market
23.2.4 InSync Healthcare Solutions in E-prescribing Market
24 Key Company Profiles
24.1 Surescripts
24.1.1 Business Overview
24.1.2 Surescripts in E-prescribing Market
24.1.3 Product Offerings
24.1.4 Key Strategies
24.1.5 Key Strengths
24.1.6 Key Opportunities
24.2 DrFirst
24.2.1 Business Overview
24.2.2 DrFirst in E-prescribing Market
24.2.3 Product Offerings
24.2.4 Key Strategies
24.2.5 Key Strengths
24.2.6 Key Opportunities
24.3 Practice Fusion
24.3.1 Business Overview
24.3.2 Practice Fusion in E-prescribing Market
24.3.3 Product Offerings
24.3.4 Key Strategies
24.3.5 Key Strengths
24.3.6 Key Opportunities
24.4 InSync Healthcare Solutions
24.4.1 Business Overview
24.4.2 InSync Healthcare Solutions in E-prescribing Market
24.4.3 Product Offerings
24.4.4 Key Strategies
24.4.5 Key Strengths
24.4.6 Key Opportunities
25 Other Prominent Vendors
25.1 eRX NETWORK
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Henry Schein
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 AdvancedMD
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 MD Toolbox
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Bravado Health
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 RXNT
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Daw Systems
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 DoseSpot
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Chetu
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Aegis Healthcare
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 SISGAIN
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Credible
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Streamline Healthcare Solutions
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Canada Health Infoway
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 DrChrono
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 BIZMATICS
25.16.1 Business Overview
25.16.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Market by Type
27.1.1 North America: Type Segmentation
27.1.2 Europe: Type Segmentation
27.1.3 APAC: Type Segmentation
27.1.4 Latin America: Type Segmentation
27.1.5 Middle East & Africa: Type Segmentation
27.2 Market by Delivery Mode
27.2.1 North America: Delivery Mode Segmentation
27.2.2 Europe: Delivery Mode Segmentation
27.2.3 APAC: Delivery Mode Segmentation
27.2.4 Latin America: Delivery Mode Segmentation
27.2.5 Middle East & Africa: Delivery Mode Segmentation
27.3 Market By Modality
27.3.1 North America: Modality Segmentation
27.3.2 Europe: Modality Segmentation
27.3.3 APAC: Modality Segmentation
27.3.4 Latin America: Modality Segmentation
27.3.5 Middle East & Africa: Modality Segmentation
27.4 Market By Medication Type
27.4.1 North America: Medication Type Segmentation
27.4.2 Europe: Medication Type Segmentation
27.4.3 APAC: Medication Type Segmentation
27.4.4 Latin America: Medication Type Segmentation
27.4.5 Middle East & Africa: Medication Type Segmentation
27.5 Market By End User
27.5.1 North America: End user Segmentation
27.5.2 Europe: End user Segmentation
27.5.3 APAC: End user Segmentation
27.5.4 Latin America: End user Segmentation
27.5.5 Middle East & Africa: End user Segmentation
27.7 Market By Geography
27.7.1 Standard E-Prescribing Geography Segmentation
27.7.2 EPCS: Geography Segmentation
27.7.3 Web & Cloud-based: Geography Segmentation
27.7.4 On-Premises & Desktop: Geography Segmentation
27.7.5 Integrated: Geography Segmentation
27.7.6 Standalone: Geography Segmentation
27.7.7 Cardiovascular: Geography Segmentation
27.7.8 Anti-infectives: Geography Segmentation
27.7.9 Oncology: Geography Segmentation
27.7.10 Pain Medication: Geography Segmentation
27.7.11 Behavioral & Mental Health: Geography Segmentation
27.7.12 Others: Geography Segmentation
27.7.13 Technology Vendors: Geography Segmentation
27.7.14 Independent & Specialty Pharmacies: Geography Segmentation
27.7.15 Healthcare Facilities: Geography Segmentation
27.7.16 PBM & Payors: Geography Segmentation
28 Appendix
28.1 Abbreviations
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the global e-prescribing market?
What is the e-prescribing market growth?
Which segment accounted for the largest e prescribing market share?
What are the key driving factors for the e-prescribing market?
Who are the leading players in the e-prescribing market?
What is the top e-prescribing industry trend in the United States?